Participants in the trials experienced significant improvements in their markers and body weight
Accessed 2025 Apr 29
Its unique mechanism of action, targeting GLP-1, GIP, and glucagon receptors, allows it to effectively regulate appetite and energy expenditure, leading to substantial weight loss
Glucagon typically raises blood sugar, but when activated alongside GLP-1 and GIP, it appears to boost metabolic rate and fat burning instead
Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Buyer Takeaway: Compounded and FDA-approved are different regulatory categories, not just price tiers